tirzepatide for addiction Weight loss drugs may stop people getting addicted to drugs and alcohol, study finds | Weight-loss drugs Semaglutide and Tirzepatide reduce alcohol

Overall, more than 80% of treatment completers finished on oral semaglutide 14 mg dose.[27] CV SAFETY PIONEER 6 was a Cardiovascular Outcome Trial (CVOT) designed to evaluate the CV safety of oral semaglutide in comparison to placebo

2025;199:5763 Why might GLP-1RAs help in ovarian cancer

Conscious of the importance of all the above, we argue for the need of and inquisitive mechanistic and clinically applied research to inform stakeholders about the potential benefits and harms of GLP-1RAs

And the two market leaders are not standing still either: Novo has initiated a pipeline expansion program across six trials spanning obesity, sleep apnoea, and knee osteoarthritis, while Lilly is studying Foundayo for type 2 diabetes, sleep apnoea, hypertension, and other indications